Review



mngf  (R&D Systems)


Bioz Verified Symbol R&D Systems is a verified supplier
Bioz Manufacturer Symbol R&D Systems manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 94
      Buy from Supplier

    Structured Review

    R&D Systems mngf
    Efficacy <t>of</t> <t>mHGF</t> versus <t>mNGF</t> treatments in accelerating corneal epithelial wound closure. (A) Representative corneal fluorescein images on day 4 after injury and (B) Kaplan–Meier survival curve analysis showing percentage of corneas with epithelial defect from day 0 to day 7. N = 8 to 10 mice/group.
    Mngf, supplied by R&D Systems, used in various techniques. Bioz Stars score: 94/100, based on 22 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/mngf/product/R&D Systems
    Average 94 stars, based on 22 article reviews
    mngf - by Bioz Stars, 2026-05
    94/100 stars

    Images

    1) Product Images from "Topical Hepatocyte Growth Factor Accelerates Wound Healing and Inhibits Scarring in Experimental Corneal Injury"

    Article Title: Topical Hepatocyte Growth Factor Accelerates Wound Healing and Inhibits Scarring in Experimental Corneal Injury

    Journal: Cornea

    doi: 10.1097/ICO.0000000000003932

    Efficacy of mHGF versus mNGF treatments in accelerating corneal epithelial wound closure. (A) Representative corneal fluorescein images on day 4 after injury and (B) Kaplan–Meier survival curve analysis showing percentage of corneas with epithelial defect from day 0 to day 7. N = 8 to 10 mice/group.
    Figure Legend Snippet: Efficacy of mHGF versus mNGF treatments in accelerating corneal epithelial wound closure. (A) Representative corneal fluorescein images on day 4 after injury and (B) Kaplan–Meier survival curve analysis showing percentage of corneas with epithelial defect from day 0 to day 7. N = 8 to 10 mice/group.

    Techniques Used:

    Efficacy of mHGF versus mNGF treatments in inhibiting corneal scar formation. (A) Representative bright-field images showing corneal scars and (B) mean scar sizes on day 7 after injury. Error bars represent standard error of the mean. N = 8 to 10 mice/group.
    Figure Legend Snippet: Efficacy of mHGF versus mNGF treatments in inhibiting corneal scar formation. (A) Representative bright-field images showing corneal scars and (B) mean scar sizes on day 7 after injury. Error bars represent standard error of the mean. N = 8 to 10 mice/group.

    Techniques Used:

    Regression of preexisting corneal scar with topical human recombinant HGF (0.1% and 0.2% dHGF) and 0.1% mHGF compared with 0.1% mNGF and PBS (control). (A) Representative images of scars on day 10 (top panel) and day 21 (lower panel) for each treatment group. (B) Mean percent reduction in preexisting corneal scars from day 8 (baseline) to day 21 or each treatment group. Error bars represent standard error of the mean. N = 8 to 10 mice/group.
    Figure Legend Snippet: Regression of preexisting corneal scar with topical human recombinant HGF (0.1% and 0.2% dHGF) and 0.1% mHGF compared with 0.1% mNGF and PBS (control). (A) Representative images of scars on day 10 (top panel) and day 21 (lower panel) for each treatment group. (B) Mean percent reduction in preexisting corneal scars from day 8 (baseline) to day 21 or each treatment group. Error bars represent standard error of the mean. N = 8 to 10 mice/group.

    Techniques Used: Recombinant, Control



    Similar Products

    mngf  (Alomone Labs)
    94
    Alomone Labs mngf
    Mngf, supplied by Alomone Labs, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/mngf/product/Alomone Labs
    Average 94 stars, based on 1 article reviews
    mngf - by Bioz Stars, 2026-05
    94/100 stars
    		  Buy from Supplier
    mngf  (R&D Systems)
    94
    R&D Systems mngf
    Efficacy <t>of</t> <t>mHGF</t> versus <t>mNGF</t> treatments in accelerating corneal epithelial wound closure. (A) Representative corneal fluorescein images on day 4 after injury and (B) Kaplan–Meier survival curve analysis showing percentage of corneas with epithelial defect from day 0 to day 7. N = 8 to 10 mice/group.
    Mngf, supplied by R&D Systems, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/mngf/product/R&D Systems
    Average 94 stars, based on 1 article reviews
    mngf - by Bioz Stars, 2026-05
    94/100 stars
    		  Buy from Supplier
    2.5s murine nerve growth factor (mngf)  (Promega)
    90
    Promega 2.5s murine nerve growth factor (mngf)
    Efficacy <t>of</t> <t>mHGF</t> versus <t>mNGF</t> treatments in accelerating corneal epithelial wound closure. (A) Representative corneal fluorescein images on day 4 after injury and (B) Kaplan–Meier survival curve analysis showing percentage of corneas with epithelial defect from day 0 to day 7. N = 8 to 10 mice/group.
    2.5s Murine Nerve Growth Factor (Mngf), supplied by Promega, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/2.5s murine nerve growth factor (mngf)/product/Promega
    Average 90 stars, based on 1 article reviews
    2.5s murine nerve growth factor (mngf) - by Bioz Stars, 2026-05
    90/100 stars
    		  Buy from Supplier
    mngf 25 s  (Promega)
    90
    Promega mngf 25 s
    Efficacy <t>of</t> <t>mHGF</t> versus <t>mNGF</t> treatments in accelerating corneal epithelial wound closure. (A) Representative corneal fluorescein images on day 4 after injury and (B) Kaplan–Meier survival curve analysis showing percentage of corneas with epithelial defect from day 0 to day 7. N = 8 to 10 mice/group.
    Mngf 25 S, supplied by Promega, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/mngf 25 s/product/Promega
    Average 90 stars, based on 1 article reviews
    mngf 25 s - by Bioz Stars, 2026-05
    90/100 stars
    		  Buy from Supplier
    mngf 25s  (Promega)
    90
    Promega mngf 25s
    Efficacy <t>of</t> <t>mHGF</t> versus <t>mNGF</t> treatments in accelerating corneal epithelial wound closure. (A) Representative corneal fluorescein images on day 4 after injury and (B) Kaplan–Meier survival curve analysis showing percentage of corneas with epithelial defect from day 0 to day 7. N = 8 to 10 mice/group.
    Mngf 25s, supplied by Promega, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/mngf 25s/product/Promega
    Average 90 stars, based on 1 article reviews
    mngf 25s - by Bioz Stars, 2026-05
    90/100 stars
    		  Buy from Supplier
    mngf 2 5  (Alomone Labs)
    94
    Alomone Labs mngf 2 5
    Efficacy <t>of</t> <t>mHGF</t> versus <t>mNGF</t> treatments in accelerating corneal epithelial wound closure. (A) Representative corneal fluorescein images on day 4 after injury and (B) Kaplan–Meier survival curve analysis showing percentage of corneas with epithelial defect from day 0 to day 7. N = 8 to 10 mice/group.
    Mngf 2 5, supplied by Alomone Labs, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/mngf 2 5/product/Alomone Labs
    Average 94 stars, based on 1 article reviews
    mngf 2 5 - by Bioz Stars, 2026-05
    94/100 stars
    		  Buy from Supplier

    Image Search Results


    Efficacy of mHGF versus mNGF treatments in accelerating corneal epithelial wound closure. (A) Representative corneal fluorescein images on day 4 after injury and (B) Kaplan–Meier survival curve analysis showing percentage of corneas with epithelial defect from day 0 to day 7. N = 8 to 10 mice/group.

    Journal: Cornea

    Article Title: Topical Hepatocyte Growth Factor Accelerates Wound Healing and Inhibits Scarring in Experimental Corneal Injury

    doi: 10.1097/ICO.0000000000003932

    Figure Lengend Snippet: Efficacy of mHGF versus mNGF treatments in accelerating corneal epithelial wound closure. (A) Representative corneal fluorescein images on day 4 after injury and (B) Kaplan–Meier survival curve analysis showing percentage of corneas with epithelial defect from day 0 to day 7. N = 8 to 10 mice/group.

    Article Snippet: Topical ocular treatments included PBS alone and 0.1% mNGF (murine recombinant nerve growth factor), 0.1% mHGF (murine recombinant hepatocyte growth factor), and 0.1% and 0.2% deleted HGF (dHGF) (a deleted variant of recombinant human hepatocyte growth factor), each formulated in PBS. mHGF (cat# 2207-HG/CF) and mNGF (cat# 1156-NG-100/CF) were obtained from RnD Systems, while dHGF was obtained from Kringle Pharma.

    Techniques:

    Efficacy of mHGF versus mNGF treatments in inhibiting corneal scar formation. (A) Representative bright-field images showing corneal scars and (B) mean scar sizes on day 7 after injury. Error bars represent standard error of the mean. N = 8 to 10 mice/group.

    Journal: Cornea

    Article Title: Topical Hepatocyte Growth Factor Accelerates Wound Healing and Inhibits Scarring in Experimental Corneal Injury

    doi: 10.1097/ICO.0000000000003932

    Figure Lengend Snippet: Efficacy of mHGF versus mNGF treatments in inhibiting corneal scar formation. (A) Representative bright-field images showing corneal scars and (B) mean scar sizes on day 7 after injury. Error bars represent standard error of the mean. N = 8 to 10 mice/group.

    Article Snippet: Topical ocular treatments included PBS alone and 0.1% mNGF (murine recombinant nerve growth factor), 0.1% mHGF (murine recombinant hepatocyte growth factor), and 0.1% and 0.2% deleted HGF (dHGF) (a deleted variant of recombinant human hepatocyte growth factor), each formulated in PBS. mHGF (cat# 2207-HG/CF) and mNGF (cat# 1156-NG-100/CF) were obtained from RnD Systems, while dHGF was obtained from Kringle Pharma.

    Techniques:

    Regression of preexisting corneal scar with topical human recombinant HGF (0.1% and 0.2% dHGF) and 0.1% mHGF compared with 0.1% mNGF and PBS (control). (A) Representative images of scars on day 10 (top panel) and day 21 (lower panel) for each treatment group. (B) Mean percent reduction in preexisting corneal scars from day 8 (baseline) to day 21 or each treatment group. Error bars represent standard error of the mean. N = 8 to 10 mice/group.

    Journal: Cornea

    Article Title: Topical Hepatocyte Growth Factor Accelerates Wound Healing and Inhibits Scarring in Experimental Corneal Injury

    doi: 10.1097/ICO.0000000000003932

    Figure Lengend Snippet: Regression of preexisting corneal scar with topical human recombinant HGF (0.1% and 0.2% dHGF) and 0.1% mHGF compared with 0.1% mNGF and PBS (control). (A) Representative images of scars on day 10 (top panel) and day 21 (lower panel) for each treatment group. (B) Mean percent reduction in preexisting corneal scars from day 8 (baseline) to day 21 or each treatment group. Error bars represent standard error of the mean. N = 8 to 10 mice/group.

    Article Snippet: Topical ocular treatments included PBS alone and 0.1% mNGF (murine recombinant nerve growth factor), 0.1% mHGF (murine recombinant hepatocyte growth factor), and 0.1% and 0.2% deleted HGF (dHGF) (a deleted variant of recombinant human hepatocyte growth factor), each formulated in PBS. mHGF (cat# 2207-HG/CF) and mNGF (cat# 1156-NG-100/CF) were obtained from RnD Systems, while dHGF was obtained from Kringle Pharma.

    Techniques: Recombinant, Control